-
The Food and Drug Administration might finally let 'the pill' be sold over the counter, but there's a catch.
-
The FDA should reclassify the opioid overdose antidote naloxone, approved for use in 1971 to rescue overdose victims for the past few decades, as an over‐the‐counter drug.
-
A new study finds that there is no link between how much money is spent on research and development and how much drugs cost.
-
It's a recipe for trouble and maybe even a trip to the hospital.
-
A new report from the Wall Street Journal says that the Food and Drug Administration is likely to approve new COVID-19 booster shots this week, before the vaccines are tested on people.
-
The order the Food and Drug Administration issued last month mandating the e-cigarette manufacturer Juul to remove its vape goods from US shelves has been temporarily administratively stayed as of this Tuesday.
-
The transparency of our government is one of the foundational qualities of the United States. When members of the public want to learn more about how government works, they turn to the Freedom of Information Act.
-
This latest FDA blunder serves as a sobering reminder of how entrenched, strong government agencies jeopardize development and hurt society.
-
Pfizer and BioNTech said they will ask the feds for emergency approval of their experimental coronavirus vaccine on Friday.
-
The Food and Drug Administration on Monday issued an emergency clearance to Eli Lilly’s experimental COVID-19 antibody treatment.
The drug, praised by President Trump, was proven effective in
The Food and Drug Administration might finally let 'the pill' be sold over the counter, but there's a catch.
